TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31556650

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavioral treatments (TF-CBT)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Present-Centered Therapy (comparison arm in 2 trials)
Number of subjects: 702
Study: 28424222

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Eluting Balloon (PEB) angioplasty and stenting
Number of subjects: 155

Group type: COMPARATOR
Intervention: Plain Balloon Angioplasty (BA) and stenting
Number of subjects: 155

Group type: COMPARATOR
Intervention: Directional Atherectomy (DA) with distal protection and bailout stenting
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 155
Study: 25884986

Group type: EXPERIMENTAL
Intervention: Workplace Walk‐to‐Work promoters providing materials and support over 10 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual practice in control workplaces.
Number of subjects: 0
Study: 23948637

Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors (SRI)
Number of subjects: 128
Study: 20652755

Group type: EXPERIMENTAL
Intervention: Axillary dissection
Number of subjects: 671

Group type: COMPARATOR
Intervention: No axillary dissection
Number of subjects: 671
Study: 19218250

Group type: EXPERIMENTAL
Intervention: Posterior sub-Tenon capsule injection of triamcinolone acetonide (PSTA) 20 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: No injection (Control)
Number of subjects: 41
Study: 17641814

Group type: EXPERIMENTAL
Intervention: Vibrotactile feedback (vibration pulse to the trigeminal distribution on the forehead)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No vibrotactile feedback (control condition)
Number of subjects: 39
Study: 14632810

Group type: EXPERIMENTAL
Intervention: Mycobacterium vaccae suspension
Number of subjects: 56

Group type: COMPARATOR
Intervention: Buffer solution (placebo)
Number of subjects: 56
Study: 10381711

Group type: EXPERIMENTAL
Intervention: Baby Check and Play It Safe (n=497)
Number of subjects: 997

Group type: COMPARATOR
Intervention: Play It Safe alone (control group, n=500)
Number of subjects: 997
Study: 8740332

Group type: EXPERIMENTAL
Intervention: Vinorelbine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 0
Study: 2065534

Group type: EXPERIMENTAL
Intervention: Intrapartum amnioinfusion for replacement (IAR) with normal saline solution
Number of subjects: 177

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 177
Study: 6627827

Group type: COMPARATOR
Intervention: 5 gm activated charcoal every 2 hr for 6 doses
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 gm activated charcoal every 2 hr for 6 doses
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 gm activated charcoal every 4 hr for 3 doses
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 gm activated charcoal every hr
Number of subjects: 6
Study: 3909842

Group type: EXPERIMENTAL
Intervention: gelatin 5.5 pc
Number of subjects: 18

Group type: COMPARATOR
Intervention: serum protein solution
Number of subjects: 18
Study: 28836577

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 27521283

Group type: EXPERIMENTAL
Intervention: DADDS-G (Death and Dying Distress Scale)
Number of subjects: 77
Study: 24796045

Group type: EXPERIMENTAL
Intervention: Syndrome-differentiation acupuncture
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Regular acupuncture
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-acupoint group
Number of subjects: 105
Study: 22607867

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 1012
Study: 20817410

Group type: EXPERIMENTAL
Intervention: ASTP (Alcohol Skills Training Program)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: ASTP for mandated students
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Voluntary sample
Number of subjects: 204
Study: 18161760

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic inspection only
Number of subjects: 40
Study: 15832634

Group type: EXPERIMENTAL
Intervention: Abstract analogy to specific training items
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surface characteristics of items
Number of subjects: 0

Group type: COMPARATOR
Intervention: Grammaticality
Number of subjects: 0
Study: 12788175

Group type: EXPERIMENTAL
Intervention: Adjuvant postmastectomy radiotherapy (RT)
Number of subjects: 656

Group type: COMPARATOR
Intervention: No radiotherapy (Control)
Number of subjects: 656
Study: 15493096

Group type: EXPERIMENTAL
Intervention: Word identification training (35 hours)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Metacognitive phonics program
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Phonological training program
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Phonological deficits
Number of subjects: 166
Study: 9003465

Group type: EXPERIMENTAL
Intervention: Bestatin 90 and 180 mg daily for 60 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bestatin 10 and 30 mg daily for 60 days
Number of subjects: 30
Study: 1289676

Group type: EXPERIMENTAL
Intervention: TRUS-guided systematic random biopsy (TRUSPNB)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DRE, TRUS, TRUSPNB
Number of subjects: 100
Study: 6748872

Group type: EXPERIMENTAL
Intervention: Delta-Ag positive group (24 patients always delta-Ag positive and 2 became delta-Ag positive during observation)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Delta-Ag negative group (10 patients always delta-Ag negative and 9 became delta-Ag negative during the study)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prednisolone treatment (15 mg daily)
Number of subjects: 45
Study: 30641146

Group type: EXPERIMENTAL
Intervention: Asthma Adherence Pathway (AAP) application with electronic adherence monitors
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not monitored for MF/F adherence)
Number of subjects: 39
Study: 29939895

Group type: EXPERIMENTAL
Intervention: Intravenous Tranexamic Acid (TXA)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control (no TXA)
Number of subjects: 156
Study: 27576483

Group type: EXPERIMENTAL
Intervention: Combination therapy of etanercept and fumarates
Number of subjects: 33

Group type: COMPARATOR
Intervention: Etanercept monotherapy
Number of subjects: 33
Study: 24447116

Group type: EXPERIMENTAL
Intervention: High-intensity (HI) home visitation coaching program (55 sessions)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Low-intensity (LI) condition (monthly phone calls, printed materials, community referrals)
Number of subjects: 361
Study: 22962863

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle intervention
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146
Study: 19925875

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) plus high-dose corticosteroids
Number of subjects: 32
Study: 18574157

Group type: EXPERIMENTAL
Intervention: Induction with fluorouracil, cisplatin, and paclitaxel followed by fluorouracil plus paclitaxel with 50.4 Gy of radiation (arm A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Induction with paclitaxel plus cisplatin followed by the same chemotherapy with 50.4 Gy of radiation (arm B)
Number of subjects: 84
Study: 16013780

Group type: EXPERIMENTAL
Intervention: Additional counselling by paramedics
Number of subjects: 174

Group type: COMPARATOR
Intervention: Routine diagnostic procedure (Control)
Number of subjects: 174
Study: 12453928

Group type: EXPERIMENTAL
Intervention: i.m. bupivacaine (5 mg ml(‐1)) 1 mg kg(‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: i.m. lidocaine (100 mg ml(‐1)) 2 mg kg(‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: i.m. saline 5 ml
Number of subjects: 60
Study: 10703901

Group type: EXPERIMENTAL
Intervention: Saline infusion (2 l NaCl 0.9% over 2 h) during high salt (HS) diet
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Saline infusion (2 l NaCl 0.9% over 2 h) during low salt (LS) diet
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Saline infusion (2 l NaCl 0.9% over 2 h)
Number of subjects: 39
Study: 8794966

Group type: EXPERIMENTAL
Intervention: C31G rinse
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CPC rinses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stannous fluoride paste
Number of subjects: 20

Group type: COMPARATOR
Intervention: Minus CPC control rinse
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water (placebo control)
Number of subjects: 20
Study: 1743373

Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream (pretreated side)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Non-pretreated side (control)
Number of subjects: 5
Study: 7072476

Group type: EXPERIMENTAL
Intervention: Epidural morphine 4 mg in 10 ml saline
Number of subjects: 14

Group type: COMPARATOR
Intervention: 10 ml saline (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Epidural morphine 4 mg in saline (if pain score exceeded 5)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline (if pain score exceeded 5)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 14
Study: 30991969

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly injectable formulation (AOM)
Number of subjects: 193
Study: 27637407

Group type: EXPERIMENTAL
Intervention: Comprehensive management (active intervention)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ordinary management (control)
Number of subjects: 102
Study: 25879016

Group type: EXPERIMENTAL
Intervention: CHG-impregnated dressing
Number of subjects: 308

Group type: COMPARATOR
Intervention: Conventional draping
Number of subjects: 308
Study: 22744704

Group type: EXPERIMENTAL
Intervention: Laser‐PAS with 50 ms ISI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repetitive laser pulses and rTMS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser‐PAS with laser pulses ipsilaterally to M1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TMS after Laser‐PAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TES after Laser‐PAS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Memantine (NMDA receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: α‐lipoic acid (placebo)
Number of subjects: 0
Study: 18829205

Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin aspart every 2 h until BG < 200 mg/dL
Number of subjects: 54

Group type: COMPARATOR
Intervention: Historical controls with DM and an ED admission BG > 200 mg/dL
Number of subjects: 54
Study: 19515731

Group type: EXPERIMENTAL
Intervention: Large bite size (approximately 15 g)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Small bite size (approximately 5 g)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Free OPT
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: OPT of 3 s
Number of subjects: 22
Study: 17083378

Group type: EXPERIMENTAL
Intervention: 2-week therapy with omeprazole, amoxicillin, and clarithromycin
Number of subjects: 486

Group type: COMPARATOR
Intervention: 1-week therapy with omeprazole, amoxicillin, and clarithromycin
Number of subjects: 486
Study: 15010386

Group type: EXPERIMENTAL
Intervention: Modern radiotherapy techniques
Number of subjects: 62
Study: 11393609

Group type: EXPERIMENTAL
Intervention: Mediation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Litigation
Number of subjects: 0
Study: 9269069

Group type: EXPERIMENTAL
Intervention: Random donor platelet (RDP) transfusion
Number of subjects: 2
Study: 8329794

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 20
Study: 2885767

Group type: EXPERIMENTAL
Intervention: Iopamidol (nonionic low-osmolal contrast medium)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Diatrizoate (ionic high-osmolal contrast medium)
Number of subjects: 18
Study: 29604186

Group type: EXPERIMENTAL
Intervention: Baminercept (100 mg subcutaneous injections every week for 24 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (matching injections)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Baminercept
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 27709863

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Steroid (TA) injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Steroid (TA) injection (first)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection (first)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Steroid (TA) first, Hyaluronic acid (HA) later
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) first, Steroid (TA) later
Number of subjects: 30
Study: 26010325

Group type: EXPERIMENTAL
Intervention: Chocolate restriction (non-chocolate snacks provided for 3 weeks)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Post-restriction period
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pre- and post-restriction periods
Number of subjects: 56
Study: 24314204

Group type: EXPERIMENTAL
Intervention: Brief personalized feedback intervention materials
Number of subjects: 185

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 185
Study: 21076997

Group type: EXPERIMENTAL
Intervention: Alternative transportation strategy during the Olympic Games
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline period (1-30 June)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-Olympic period
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cumulative ozone concentrations of 70 to 100 ppb and 100 ppb or more
Number of subjects: 0
Study: 19340896

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants (TCAs) including amitriptyline, imipramine, desipramine, doxepin, and trimipramine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants (TCAs)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 16764963

Group type: EXPERIMENTAL
Intervention: Nurse-based prompt intervention
Number of subjects: 1176
Study: 15504191

Group type: EXPERIMENTAL
Intervention: Clonidine (5 microg kg(‐1) and atropine 40 microg kg(‐1); group C, n = 48)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Midazolam (300 microg kg(‐1) and atropine 40 microg kg(‐1); group M, n = 52)
Number of subjects: 100
Study: 11300388

Group type: EXPERIMENTAL
Intervention: Epidural solution with fentanyl (SBAF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Epidural solution without fentanyl (SBA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Propofol anaesthesia and epidural solution without fentanyl (PBA)
Number of subjects: 42
Study: 9131364

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-coated catheters
Number of subjects: 221

Group type: COMPARATOR
Intervention: Uncoated catheters
Number of subjects: 221
Study: 7890063

Group type: EXPERIMENTAL
Intervention: E2 (estradiol)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: P (progesterone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of E2 and P
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2795526

Group type: EXPERIMENTAL
Intervention: Moderate aerobic training programme
Number of subjects: 47

Group type: COMPARATOR
Intervention: Attention-placebo strength and flexibility training programme
Number of subjects: 47
Study: 342295

Group type: EXPERIMENTAL
Intervention: Diflucortolone valerate 0.1% cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diflucortolone valerate 0.1% ointment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diflucortolone valerate 0.1% fatty ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluocinolone acetonide 0.025% ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluocinolone acetonide 0.025% cream
Number of subjects: 0
Study: 31319510

Group type: EXPERIMENTAL
Intervention: Anserine/Carnosine Supplementation (750 mg of anserine and 250 mg of carnosine per day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Anserine/Carnosine Supplementation (750 mg of anserine and 250 mg of carnosine per day) in APOE4 (+) subjects
Number of subjects: 54
Study: 28690011

Group type: EXPERIMENTAL
Intervention: Nintedanib plus pemetrexed/cisplatin
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo plus pemetrexed/cisplatin
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Nintedanib maintenance treatment
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo maintenance treatment
Number of subjects: 450
Study: 25397860

Group type: EXPERIMENTAL
Intervention: Viewing the quit plan (CBT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tracking practice of letting urges pass (ACT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tracking ACT skill practice
Number of subjects: 76
Study: 26221044

Group type: EXPERIMENTAL
Intervention: 60% W max aerobic training intensity (group 1, n = 17)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 80% W max aerobic training intensity (group 2, n = 17)
Number of subjects: 34
Study: 23680226

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) - 1 g intravenously as a bolus immediately after randomization, followed by continuous infusion of 1 g per 8 hours until aneurysm treatment or maximum of 24 hours.
Number of subjects: 950

Group type: COMPARATOR
Intervention: Standard treatment without TXA.
Number of subjects: 950
Study: 20525844

Group type: EXPERIMENTAL
Intervention: DAREA score
Number of subjects: 0
Study: 19140662

Group type: EXPERIMENTAL
Intervention: Positive prior contact with grandchildren (Experiment 1)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Imagined intergenerational contact (Experiment 2)
Number of subjects: 135
Study: 16925104

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating proteins (epoetin alfa, epoetin beta, darbepoetin alfa)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early treatment of mild anemia with erythropoietic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietic therapy
Number of subjects: 0
Study: 12958322

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole 400 mg/d
Number of subjects: 591

Group type: COMPARATOR
Intervention: Aspirin 30 to 325 mg/d
Number of subjects: 591
Study: 11190751

Group type: EXPERIMENTAL
Intervention: Forced expiration through the nose (PNEF) in NANIPER patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Forced expiration through the nose (PNEF) in controls
Number of subjects: 30
Study: 9150630

Group type: EXPERIMENTAL
Intervention: The Images Within program (experimental group)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 588
Study: 7514030

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) (Filgrastim) at a dose of 5 micrograms/kg/day i.m. from day 6 to day 19
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (DHAD) 12 mg m-2 i.v. on day 1; Ifosfamide (IFO) 4 g m-2 i.v. on days 1 and 2; Mesna 800 mg m-2 i.v. t.i.d. on days 1 and 2
Number of subjects: 19
Study: 3502542

Group type: EXPERIMENTAL
Intervention: Alinidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 32
Study: 29268948

Group type: EXPERIMENTAL
Intervention: Atezolizumab 1200 mg every 3 weeks
Number of subjects: 931

Group type: COMPARATOR
Intervention: Chemotherapy (vinflunine 320 mg/m2, paclitaxel 175 mg/m2, or 75 mg/m2 docetaxel) every 3 weeks
Number of subjects: 931
Study: 26788432

Group type: EXPERIMENTAL
Intervention: Mobile devices corresponding to their condition(s) (hypertension: Withings Blood Pressure Monitor; diabetes: Sanofi iBGStar Blood Glucose Meter; arrhythmia: AliveCor Mobile ECG) and an iPhone with linked tracking applications for 6 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard disease management program (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile devices and online health management system (Intervention group)
Number of subjects: 0
Study: 23601128

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Physiotherapy core stability exercises
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: FES combined with physiotherapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adding gluteal stimulation to FES
Number of subjects: 28
Study: 23455538

Group type: EXPERIMENTAL
Intervention: Manual removal of placenta
Number of subjects: 100

Group type: COMPARATOR
Intervention: Spontaneous removal of placenta
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 20636964

Group type: EXPERIMENTAL
Intervention: Anaesthetic cream (EMLA) applied to the lower leg for 1.5 hours
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo cream applied to the lower leg for 1.5 hours
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Anaesthetic cream (EMLA)
Number of subjects: 37
Study: 18402899

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 10001
Study: 17240783

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) meal, 2 g/kg body mass CHO, ingested 3 hours prior to exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: High Glycemic Index (HGI) meal, 2 g/kg body mass CHO, ingested 3 hours prior to exercise
Number of subjects: 8
Study: 12834935

Group type: EXPERIMENTAL
Intervention: Ritodrine intravenously (N=90)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Nifedipine orally (N=95)
Number of subjects: 185
Study: 10962124

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme in idiopathic dilated cardiomyopathy
Number of subjects: 24